|
| Mr. Richard Bauer, CEO & President |
| Responsible for Marketing, Sales, and Customer activities worldwide, Mr. Bauer joined Cloverleaf from Expand Networks where he served as President of the company. Prior to Expand, Mr. Bauer served as President and Business Unit Manager of PowerDsine, Inc., NY (NASDAQ:PDSN), and was instrumental in leading the company to a successful public offering. |
| Mr. Joseph Klein, COO & Founder |
Previously Manager of Marketing & Sales, Information Systems Division at Elta Systems / Israel Aircraft Industries. Responsibilities included marketing to the Defense Industry, and business development of new commercial markets for civilian-repurposed products. Prior to that, he led the Software Department of the Division which grew from five to fifty five engineers in the fields of R&D and customer support. Joseph also held senior positions at Astronautics, including heading the Software Department and managing the company's IT operations and data center, and at Elbit Systems. Joseph has a Masters in Scientific Management from Boston University and B.Sc. in Mathematics and Computer Science from the Bar-Ilan University.
|
| Dr. Elic Yavor, CTO & Founder |
Previously Senior System Engineer and Architect for Parallel Signal Processors, Highly Scalable Computer Architectures and Switching Fabric Networks at Elta Systems / Israel Aircraft Industries. Elic received the Kaplan Prize from the Government of Israel for the Best Industrial Project of the year 1997. Prior to his years at Elta, Elic founded and led two start-ups from 1981 through 1992. Elic holds a PhD in Mathematics from the Weizmann Institute of Science and Stanford University.
|
| Mr. Yossi Haas, VP Finance |
| Mr. Haas is a Certified Public Accountant, holding a B.A. in Accounting and Economics from the College of Management in Tele Aviv, and a M.Sc. from Hebrew University, Jerusalem. Mr. Haas brings with him over 16 years of experience in the high-tech environment. He has served as CFO in telecommunications companies such as Comgates and Inspiair, and he has performed financial executive duties in the biotechnology sector as well. |
|
|
|